Cargando…

Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)

BACKGROUND: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, XiaoXiao, Shi, Ming, Wang, Qifei, Hui, Jessica, Shofaro, Joshua Hui, Erkhembayar, Ryenchindorj, Hui, Mizhou, Gao, Chenzhe, Gantumur, Munkh-Amgalan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846287/
https://www.ncbi.nlm.nih.gov/pubmed/36686276
http://dx.doi.org/10.2147/JIR.S393495
_version_ 1784871141196693504
author Jia, XiaoXiao
Shi, Ming
Wang, Qifei
Hui, Jessica
Shofaro, Joshua Hui
Erkhembayar, Ryenchindorj
Hui, Mizhou
Gao, Chenzhe
Gantumur, Munkh-Amgalan
author_facet Jia, XiaoXiao
Shi, Ming
Wang, Qifei
Hui, Jessica
Shofaro, Joshua Hui
Erkhembayar, Ryenchindorj
Hui, Mizhou
Gao, Chenzhe
Gantumur, Munkh-Amgalan
author_sort Jia, XiaoXiao
collection PubMed
description BACKGROUND: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the identification of its indications, and molecular mechanisms are of great significance for its clinical application. The previous studies showed that the clinical effects of injectable 35kDa B-HA result from B-HA binding to multiple receptors in different cells, tissues, and organs. This study lays the foundation for further studies on the comprehensive clinical effects of injectable B-HA. METHODS: We elaborated on the production process, bioactivity assay, efficacy analyses, and safety evaluation of an injectable novel HA fragment with an average molecular weight of 35 kDa (35 kDa B-HA), produced by recombinant human hyaluronidase PH20 digestion. RESULTS: The results showed that 35 kDa B-HA induced human erythrocyte aggregation (rouleaux formation) and accelerated erythrocyte sedimentation rates through the CD44 receptor. B-HA application and injection treatment significantly promoted the removal of mononuclear cells from the site of inflammation and into the lymphatic circulation. At a low concentration, 35 kDa B-HA inhibited production of reactive oxygen species and tumor necrosis factor by neutrophils; at a higher concentration, 35 kDa B-HA promoted the migration of monocytes. Furthermore, 35 kDa B-HA significantly inhibited the migration of neutrophils with or without lipopolysaccharide treatment, suggesting that in local tissues, higher concentrations of 35 kDa B-HA have antiinflammatory effects. After (99m)Tc radiolabeled 35 kDa B-HA was intravenously injected into mice, it quickly entered into the spleen, liver, lungs, kidneys and other organs through the blood circulation. CONCLUSION: This study demonstrated that the HA fragment B-HA has good tissue permeability and antiinflammatory effects, laying a theoretical foundation for further clinical studies.
format Online
Article
Text
id pubmed-9846287
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98462872023-01-19 Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35) Jia, XiaoXiao Shi, Ming Wang, Qifei Hui, Jessica Shofaro, Joshua Hui Erkhembayar, Ryenchindorj Hui, Mizhou Gao, Chenzhe Gantumur, Munkh-Amgalan J Inflamm Res Original Research BACKGROUND: Hyaluronic acid (HA) and HA fragments interact with a variety of human body receptors and are involved in the regulation of various physiological functions and leukocyte trafficking in the body. Accordingly, the development of an injectable HA fragment with good tissue permeability, the identification of its indications, and molecular mechanisms are of great significance for its clinical application. The previous studies showed that the clinical effects of injectable 35kDa B-HA result from B-HA binding to multiple receptors in different cells, tissues, and organs. This study lays the foundation for further studies on the comprehensive clinical effects of injectable B-HA. METHODS: We elaborated on the production process, bioactivity assay, efficacy analyses, and safety evaluation of an injectable novel HA fragment with an average molecular weight of 35 kDa (35 kDa B-HA), produced by recombinant human hyaluronidase PH20 digestion. RESULTS: The results showed that 35 kDa B-HA induced human erythrocyte aggregation (rouleaux formation) and accelerated erythrocyte sedimentation rates through the CD44 receptor. B-HA application and injection treatment significantly promoted the removal of mononuclear cells from the site of inflammation and into the lymphatic circulation. At a low concentration, 35 kDa B-HA inhibited production of reactive oxygen species and tumor necrosis factor by neutrophils; at a higher concentration, 35 kDa B-HA promoted the migration of monocytes. Furthermore, 35 kDa B-HA significantly inhibited the migration of neutrophils with or without lipopolysaccharide treatment, suggesting that in local tissues, higher concentrations of 35 kDa B-HA have antiinflammatory effects. After (99m)Tc radiolabeled 35 kDa B-HA was intravenously injected into mice, it quickly entered into the spleen, liver, lungs, kidneys and other organs through the blood circulation. CONCLUSION: This study demonstrated that the HA fragment B-HA has good tissue permeability and antiinflammatory effects, laying a theoretical foundation for further clinical studies. Dove 2023-01-13 /pmc/articles/PMC9846287/ /pubmed/36686276 http://dx.doi.org/10.2147/JIR.S393495 Text en © 2023 Jia et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Jia, XiaoXiao
Shi, Ming
Wang, Qifei
Hui, Jessica
Shofaro, Joshua Hui
Erkhembayar, Ryenchindorj
Hui, Mizhou
Gao, Chenzhe
Gantumur, Munkh-Amgalan
Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
title Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
title_full Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
title_fullStr Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
title_full_unstemmed Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
title_short Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35)
title_sort anti-inflammatory effects of the 35kda hyaluronic acid fragment (b-ha/ha35)
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9846287/
https://www.ncbi.nlm.nih.gov/pubmed/36686276
http://dx.doi.org/10.2147/JIR.S393495
work_keys_str_mv AT jiaxiaoxiao antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35
AT shiming antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35
AT wangqifei antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35
AT huijessica antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35
AT shofarojoshuahui antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35
AT erkhembayarryenchindorj antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35
AT huimizhou antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35
AT gaochenzhe antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35
AT gantumurmunkhamgalan antiinflammatoryeffectsofthe35kdahyaluronicacidfragmentbhaha35